Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Dtsch Med Wochenschr ; 133(48): 2500-4, 2008 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-19021079

RESUMO

BACKGROUND AND OBJECTIVE: The multiple organ dysfunction syndrome (MODS), a failure of two or more organ systems, is the endstage of initial trigger events in diseases such as acute coronary syndrome or sepsis. The mortality is high (40 - 60 %). The present study aimed to detect whether beta-adrenergic blockers (BAB) which may affect sympathetic-parasympathetic balance have a positive influence on outcome. METHODS: Data on 157 patients with MODS (83 male, 74 female, mean age 61.3 +/- 13.4 years) were retrospectively analysed concerning BAB medication and autonomic dysfunction. A 24-hour-Holter-ECG which had been applied within the initial 48 hours of illness was analysed for heart rate variability (HRV). All patients were followed to determine 28-day mortality. RESULTS: 69 of the 157 MODS patients had received BAB. This treatment was associated with a higher survival probability (hazard ratio [HR] 0.4, 95 % confidence interval [CI] 0.23 - 0.68; p = 0.001). Survival benefit was especially seen in the subgroup of MODS patients who had an ischemically triggered MODS (HR 0.2 [0.1 - 0.5], p = 0.001). HRV was less reduced in the BAB group compared to patients without this medication. CONCLUSION: MODS patients treated with beta-adrenercic blockers may have a survival benefit which is especially seen in the subgroup of MODS patients with ischemically triggered MODS. Moreover, BAB medication is associated with a less pronounced autonomic dysfunction in MODS (especially the vagal modulation of heart rate) which might result in a lower inflammatory response. Hence, future prospective studies have to show the relevance of beta-adrenergic blockers in MODS.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Sistema Nervoso Autônomo/efeitos dos fármacos , Insuficiência de Múltiplos Órgãos/tratamento farmacológico , Insuficiência de Múltiplos Órgãos/fisiopatologia , Antagonistas Adrenérgicos beta/farmacologia , Sistema Nervoso Autônomo/fisiologia , Eletrocardiografia Ambulatorial , Feminino , Frequência Cardíaca/efeitos dos fármacos , Humanos , Masculino , Pessoa de Meia-Idade , Insuficiência de Múltiplos Órgãos/mortalidade , Estudos Retrospectivos
2.
Dtsch Med Wochenschr ; 130(12): 648-51, 2005 Mar 24.
Artigo em Alemão | MEDLINE | ID: mdl-15776347

RESUMO

HISTORY: A 24-year-old woman was admitted for treatment of a meningococcal infection accompanied by fulminant autonomic dysfunction. INVESTIGATIONS: Laboratory tests indicated acute renal failure and disseminated intravascular coagulopathy (creatinine 183 mmol, D-dimer 1.52 mg/l). The initial central venous oxygen saturation was 60-65%. The diagnosis of severe septic shock was supported by a high procalcitonin level of 66.7 ng/ml, CRP of 79.8 mg/l, and a WBC count of 12.2 Gpt/l. TREATMENT AND COURSE: Treatment of sepsis with antibiotics (ciprofloxacin, penicillin G, ceftriaxon and erythromycin in standard dosages), activated protein-C, hydrocortisone and GMA-embedded immunoglobulin led to complete cure and restoration of normal autonomic function. CONCLUSIONS: This case shows that even in multiple organ dysfunction syndrome autonomic dysfunction can occur which is improved by adequate treatment.


Assuntos
Doenças do Sistema Nervoso Autônomo/complicações , Infecções Meningocócicas/complicações , Insuficiência de Múltiplos Órgãos/complicações , Choque Séptico/complicações , Adulto , Antibacterianos , Arritmias Cardíacas/diagnóstico , Arritmias Cardíacas/fisiopatologia , Doenças do Sistema Nervoso Autônomo/fisiopatologia , Doenças do Sistema Nervoso Autônomo/terapia , Células Quimiorreceptoras/fisiopatologia , Terapia Combinada , Cuidados Críticos , Quimioterapia Combinada/uso terapêutico , Eletrocardiografia , Feminino , Frequência Cardíaca/fisiologia , Humanos , Imunoglobulina A/uso terapêutico , Imunoglobulina M/uso terapêutico , Infecções Meningocócicas/fisiopatologia , Infecções Meningocócicas/terapia , Insuficiência de Múltiplos Órgãos/fisiopatologia , Insuficiência de Múltiplos Órgãos/terapia , Proteína C/uso terapêutico , Proteínas Recombinantes/uso terapêutico , Limiar Sensorial/fisiologia , Choque Séptico/fisiopatologia , Choque Séptico/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA